Biotechnology company focused on gene editing
4 AI-extracted insights from 3 sources — podcasts, YouTube channels, and X/Twitter accounts.
Not enough scored insights about Intellia Therapeutics Inc. in the last 30 days yet.
The 3 sources with the most insights about Intellia Therapeutics Inc. on Kazuha.
AI-generated insights from podcasts, YouTube videos, and X posts — ordered by most recent.
Listed as one of the key publicly traded companies for investors to explore in the major investment theme of CRISPR gene-editing technology.
Bearish/Avoid, as the speaker states, 'I got burned from that years ago, and I'm done,' indicating a personal decision to no longer invest in the company.
A significant negative catalyst was mentioned for the stock: 'Intellia Patient died or is dying.'
A director made a substantial $1 million first-time ever open market purchase after the stock fell over 20%. The director's past successful timing on another stock (ABBV) adds to the high-conviction signal.
Listed as one of the key publicly traded companies for investors to explore in the major investment theme of CRISPR gene-editing technology.
Bearish/Avoid, as the speaker states, 'I got burned from that years ago, and I'm done,' indicating a personal decision to no longer invest in the company.
A significant negative catalyst was mentioned for the stock: 'Intellia Patient died or is dying.'
A director made a substantial $1 million first-time ever open market purchase after the stock fell over 20%. The director's past successful timing on another stock (ABBV) adds to the high-conviction signal.
Other assets that creators frequently mention in the same content as Intellia Therapeutics Inc..
The most active sources covering Intellia Therapeutics Inc. (NTLA) on Kazuha are @realmartinshkreli, @ceowatcher, Joe Rogan. Kazuha aggregates AI-extracted insights from podcasts, YouTube channels, and X/Twitter accounts.
Kazuha has indexed 4 AI-extracted insights about Intellia Therapeutics Inc. (NTLA) from 3 different sources. New insights are added whenever a covered creator publishes a new podcast episode, video, or post.
Creators covering Intellia Therapeutics Inc. (NTLA) most frequently also discuss NVDA, QBTS, IONQ, SRPT, BA. See the "Discussed alongside" section above for full asset pages.